BML Capital Management, LLC

Exempt adviser

CIK

1616824

Location

ZIONSVILLE, IN

Portfolio Value

Small $175,316,114

Diversification

Moderately concentrated

Filing Date

Global Rank

#6,786 / 8,807 ▼ 287

Top Industry

Biotechnology 74.3%

Period ended 4 months ago

Filed Aug 7, 2026 · 2mo

15 quarters · since Dec 2022

Regulatory profile

From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.

Holder type

Exempt adviser

Form ADV roster, Oct 1, 2026

Form ADV adviser

CRD 152244

Roster of Oct 1, 2026

Private funds

1 fund · Hedge funds

Focus by fund count, roster of Oct 1, 2026

$73,290,986 gross assets

Private funds on Schedule D 7.B.(1)

As filed Jan 31, 2024; SEC's bulk Form ADV archive ends with 2024 filings.

$73,290,986 gross assets in 1 fund Hedge funds $73,290,986 (1)

Form ADV history

Monthly rosters from Dec 2019; each row is a run with the same figures, newest first.

Rosters	Regulatory AUM	Main clients
Jun 2023 to Oct 2026	—	—
May 2023	$0	—
Dec 2019 to Apr 2023	—	—

Portfolio style

Measured from the filed 13F common-share book for Jun 30, 2026, never from the firm's own description.

Style

Concentrated

The top 10 positions are 93.8% of the book (60%+)

Turnover

Medium turnover

32.0% over the last four quarters (30% to under 100%)

Horizon

Medium horizon

Value-weighted holding period 8.3 quarters (4 to under 12)

Closest benchmark: the S&P SmallCap 600 as of 2026-06-30, active share 99.6%; sector active share 78.8% against the combined 13F book's sector weights.

Over time 15 measured quarters

How the bands are measured

Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.

Clone Performance

Build a hypothetical price-return history from this filer's public 13F holdings.

View clone backtest

Portfolio Concentration

18 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026

Top Position

36.1%

+0.5 pts

Top 5

73.6%

−5.1 pts

Top 10

93.7%

−2.2 pts

HHI

1,862

Moderately concentrated−221

Portfolio Trend

15 quarters · across all stocks

Sector Breakdown

As of Jun 30, 2026

Sector	% Portfolio	Value	Positions
Healthcare	80.5%	$141,065,275	11
Consumer Cyclical	10.4%	$18,311,250	3
Consumer Defensive	9.1%	$15,919,117	3
Technology	0.0%	$20,472	1

Last Quarter's Activity

Export CSV

Jun 30, 2026 vs Mar 31, 2026

Added To

Positions the filer increased

5 positions

Ticker	Company	Δ Shares	Shares	Value
OM	Outset Medical, Inc.	+617,500	2,519,701	$10,885,108
KHC	Kraft Heinz Co	+340,000	465,000	$10,983,300
CNTB	Connect Biopharma Holdings Ltd	+164,400	573,287	$1,364,423
KMX	Carmax Inc	+17,500	172,500	$9,123,525
PMVP	PMV Pharmaceuticals, Inc.	+10,000	5,330,000	$7,142,200
No positions match the current search.

Trimmed

Positions the filer reduced

3 positions

Ticker	Company	Δ Shares	Shares	Value
ORMP	Oramed Pharmaceuticals Inc.	−2,300,962	866,269	$4,166,753
ACRS	Aclaris Therapeutics, Inc.	−2,275,000	11,975,000	$63,347,750
AVIR	Atea Pharmaceuticals, Inc.	−106,327	6,952,330	$32,328,334
No positions match the current search.

New Positions

Positions the filer opened this quarter

1 positions

Ticker	Company	Shares	Value	Open
ENGN	enGene Therapeutics Inc.	6,669,908	$11,538,940
No positions match the current search.

Sold Out

Positions the filer fully exited

1 positions

Ticker	Company	Shares	Value	Open
—		720,787	$0
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

18 tracked positions · $175,316,114 total · filing declares 18 positions · $176,054,067 · as of Jun 30, 2026

All sectors Consumer Cyclical Consumer Defensive Healthcare Technology

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	Held (qtrs)	Est. cost/share	% of Portfolio
ACRS	Aclaris Therapeutics, Inc. Healthcare	Reduced	11,975,000	-2,275,000	$63,347,750	+18.5%	11	$1.28	36.13%
AVIR	Atea Pharmaceuticals, Inc. Healthcare	Reduced	6,952,330	-106,327	$32,328,334	−14.9%	13	$3.51	18.44%
ENGN	enGene Therapeutics Inc. Healthcare	NEW	6,669,908	NEW	$11,538,940	NEW	1	$4.08	6.58%
KHC	Kraft Heinz Co Consumer Defensive	Added	465,000	+340,000	$10,983,300	+290.7%	2	$23.20	6.26%
OM	Outset Medical, Inc. Healthcare	Added	2,519,701	+617,500	$10,885,108	+49.0%	3	$5.13	6.21%
KMX	Carmax Inc Consumer Cyclical	Added	172,500	+17,500	$9,123,525	+41.6%	3	$40.35	5.20%
TLYS	Tilly's, Inc. Consumer Cyclical	Held	2,150,000	0	$9,030,000	+3.7%	2	$2.02	5.15%
PMVP	PMV Pharmaceuticals, Inc. Healthcare	Added	5,330,000	+10,000	$7,142,200	+8.3%	10	$1.48	4.07%
TIL	Instil Bio, Inc. Healthcare	Held	645,600	0	$4,964,664	−6.7%	10	$17.47	2.83%
TGT	Target Corp Consumer Defensive	Held	37,500	0	$4,897,875	+7.8%	4	$93.84	2.79%
ORMP	Oramed Pharmaceuticals Inc. Healthcare	Reduced	866,269	-2,300,962	$4,166,753	−61.3%	14	$2.48	2.38%
JANX	Janux Therapeutics, Inc. Healthcare	Held	154,961	0	$2,380,200	+10.5%	2	$13.71	1.36%
PLRX	Pliant Therapeutics, Inc. Healthcare	Held	1,546,137	0	$1,762,596	−9.5%	3	$1.50	1.01%
CNTB	Connect Biopharma Holdings Ltd Healthcare	Added	573,287	+164,400	$1,364,423	+27.4%	4	$1.96	0.78%
IMA	ImageneBio, Inc. Healthcare	Held	200,730	0	$1,184,307	+18.0%	4	unpriced	0.68%
TSLA	Tesla, Inc. PUT Consumer Cyclical	NEW	375	NEW	$157,725	NEW	—	—	0.09%
WMT	Walmart Inc. PUT Consumer Defensive	Held	335	0	$37,942	−8.9%	—	—	0.02%
CORZ	Core Scientific, Inc./tx PUT Technology	NEW	800	NEW	$20,472	NEW	—	—	0.01%

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.